|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2134873 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08744698.5 |
| Date of filing the European patent application | 2008-03-28 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/058791 |
| Date | 2008-03-28 |
| (87) | Number | WO 2008/121899 |
| Date | 2008-10-09 |
| (30) | Number | Date | Country code |
| 908734 P | 2007-03-29 | US |
| (72) |
LAVEDAN, Christian, US
VOLPI, Simona, US
LICAMELE, Louis, US
MACK, Kendra, Tomino, US
HEATON, Callie, Michelle, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037,
US
|
| (54) | METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION |
| METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION |